Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,567.24
(
-0.67%
)
US TECH 100
23,298.80
(
-1.02%
)
Dow Jones
46,440.49
(
-0.49%
)
Brent Oil
107.54
(
0.43%
)
Bitcoin
68,069.99
(
-1.14%
)
News Focus
News Focus
Post# of 257367
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

mcbio

Send PM Follow Ignore
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

mcbio

Re: bladerunner1717 post# 143313

Tuesday, 06/05/2012 6:34:47 PM

Tuesday, June 05, 2012 6:34:47 PM

Post# of 257367

Jefferies maintains $6.00 target on ARRY

Thanks blade. Nice to see the expectation of AZN launching Phase 3 trials for selumetinib shortly (not that I am concerned they won't). Also good to see reiteration that we should have the selumetinib+DTIC BRAF melanoma data this month. ARRY is presenting tomorrow at the Jefferies conference and I'll post any meaningful notes.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today